Abstract:Understanding the interaction of Arf and Hdm2 has recently become a central issue in cancer biology. In response to hyperproliferative signals, p14(Arf) stabilizes p53 by binding to Hdm2 and inhibits the ubiquitination and subsequent proteosome-dependent degradation of p53. The medical importance of the Arf-Hdm2-p53 regulatory system is highlighted by the finding that either p53 or p14(Arf) are lost or modified in virtually all human cancers. Isolated Arf and Hdm2 domains are dynamically disordered in solution, yet they retain the ability to interact in vitro and in cellular assays. Upon binding, domains of both Arf and Hdm2 undergo a dramatic transition from disordered conformations to extended structures comprised of beta-strands. The presence of domains from both proteins are necessary and sufficient for the formation of the highly stable extended beta structures. We have mapped sites within Arf and Hdm2 that interact at a resolution of five amino acid residues using surface plasmon resonance. Surface plasmon resonance and circular dichroism spectropolarimetry confirm the presence of multiple interaction domains within each protein. Both p14(Arf) (human) and p19(Arf) (mouse) interact with Hdm2 through two short motifs present in their N termini. The Arf interacting region of Hdm2 is also composed of two short sequences located in the central acidic domain, between residues 235-264 and 270-289. The binding-induced structural transition is also induced by short peptides, 15 amino acids in length, that contain the binding motifs. Micro-injection and live cell imaging of proteins tagged with fluorescent labels was used to confirm the in vivo function of the interaction domains. Arf and Hdm2 thus appear to interact through a novel mechanism that exerts control over the cell division cycle. The novel molecular mechanism of interaction and the limited size of the protein domains involved provide opportunities for the development of anticancer therapeutics.

ARFs get the BioID treatment: what have we been missing?

Mapping the global interactome of the ARF family reveals spatial organization in cellular signaling pathways

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB

Arfs at a Glance

Arf-like GTPases: not so Arf-like after all

ARF GTPases and their GEFs and GAPs: concepts and challenges

The Arf family GTPases: Regulation of vesicle biogenesis and beyond

The Functions of the Small Arf GTPase Family in Mammals

Defining the molecular basis of Arf and Hdm2 interactions

Arf and its many interactors

Control of cell signaling by Arf GTPases and their regulators: Focus on links to cancer and other GTPase families

The Small G Proteins of the Arf Family and Their Regulators

Interspecies relationships among ADP-ribosylation factors (ARFs): Evidence of evolutionary pressure to maintain individual identities

Nomenclature for the human Arf family of GTP-binding proteins: ARF, ARL, and SAR proteins

The Mammalian ARF-like Protein 1 (arl1) is Associated with the Golgi Complex

Research Progress in ARF-GEF Gene Family

Point mutations in Arf1 reveal cooperative effects of the N-terminal extension and myristate for GTPase-activating protein catalytic activity

Characterization, Chromosomal Assignment, and Tissue Expression of A Novel Human Gene Belonging to the Arf Gap Family

Arfs and membrane lipids: sensing, generating and responding to membrane curvature